Jefferies Starts Structure Therapeutics (GPCR) at Buy
Tweet
Share
E-mailGet Alerts GPCR Hot Sheet
Price: $53.76 --0%
Rating Summary:
14 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 11 | New: 25
Rating Summary:
14 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 11 | New: 25
Join SI Premium – FREE
Jefferies analyst Chris Howerton initiates coverage on Structure Therapeutics (NASDAQ: GPCR) with a Buy rating and a price target of $34.00.
For an analyst ratings summary and ratings history on Structure Therapeutics click here. For more ratings news on Structure Therapeutics click here.
Shares of Structure Therapeutics closed at $24.00 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Barclays Starts Centrus Energy Corp. (LEU) at Equalweight
- Chardan Starts Rani Therapeutics (RANI) at Buy
- BofA Securities Upgrades Americold Realty Trust (COLD) to Neutral
Create E-mail Alert Related Categories
New CoverageRelated Entities
Jefferies & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
